ArticleRedox biology2026
4-octyl itaconate alleviates LPS-induced inflammation in Sertoli cells by inhibiting excessive autophagy.
Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial orchitis is a major cause of male infertility, yet effective therapies remain limited. Although the itaconate derivative 4-octyl itaconate (4-OI) possesses potent anti-inflammatory properties, its role in testicular inflammation is unclear. Here, we investigated the protective effects and mechanisms of 4-OI in lipopolysaccharide (LPS)-induced inflammatory injury using Sertoli cells and a mouse model of acute orchitis. LPS activated NF-κB/NLRP3 signaling and induced excessive autophagy in Sertoli cells, resulting in oxidative stress, apoptosis, disruption of tight junctions, and functional impairment. 4-OI markedly suppressed NF-κB phosphorylation and NLRP3 activation, reduced mitochondrial oxidative stress, and improved cell viability. Mechanistically, 4-OI inhibited excessive autophagy by downregulating UNC-51-like kinase 1 (ULK1) and autophagy-related proteins, thereby limiting autophagic flux. Consequently, Sertoli cell functional markers, tight junction integrity, and mitochondrial homeostasis were restored. In vivo, 4-OI alleviated testicular histopathological damage, reduced germ cell apoptosis, improved sperm quality, preserved blood-testis barrier integrity, and enhanced spermatogenic activity. Collectively, these findings identify ULK1-associated excessive autophagy as a key mechanism of inflammatory testicular injury and demonstrate that 4-OI protects against orchitis-induced reproductive dysfunction, highlighting its therapeutic potential for inflammation-associated male infertility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.